Using Existing Drugs in New Ways to Treat & Cure Diseases of Brain & Body | Dr. David Fajgenbaum

Collaboration

The lack of collaboration among scientists and healthcare professionals significantly hampers drug discovery and patient treatment. David C. Fajgenbaum likens the current state to a "Santa Claus theory," where he once imagined scientists working together like elves in a workshop to quickly deliver solutions, only to realize the reality is far less collaborative 1. Andrew Huberman echoes this sentiment, advocating for a shift from the independent investigator model to a more collaborative approach focused on solving specific diseases 1.

   

Information Gaps

Critical information gaps in the medical community often leave potential drug uses and treatment options unexplored. David C. Fajgenbaum shares a poignant example of a TNF inhibitor that could save children with DADA2, yet remained unknown to many for years 2. Andrew Huberman stresses the importance of accessible databases to bridge these gaps, allowing patients and doctors to find existing treatments more efficiently 3.

   

Self-Advocacy

Patients are encouraged to take an active role in their healthcare by exploring broader treatment options globally. Andrew Huberman notes the growing awareness of self-advocacy in health, emphasizing that many existing drugs could treat various diseases if only people were aware of them 4. David C. Fajgenbaum highlights his own journey with Castleman's disease, where he discovered life-saving treatments through repurposed drugs, underscoring the need for patients to seek out disease organizations and advocacy groups 5.